Skip to main content
. 2022 May 5;12:862564. doi: 10.3389/fonc.2022.862564

Figure 4.

Figure 4

miRNA-195-5p was down-regulated in LUAD and cell lines. (A, B)The expression of miRNA-195-5p in lung cancer examine by TCGA datasets. (C) The tumor stage of miRNA-195-5p in TCGA-LUAD examine by the UALCAN. (D) The lymph node metastases of miRNA-195-5p in TCGA-LUAD examined by the UALCAN. (E, F) The expression of miRNA-195-5p in lung cancer determines by GEO datasets. (G) The expression of miRNA-195-5p in LUAD cell lines was determined by qRT-PCR assay. (H–J)The overall survival and disease-specific survival of miRNA-195-5p in LUAD determine by the TCGA-LUAD dataset and clinical samples. (K, L) Univariate and multivariate Cox regression analyses were performed to determine miRNA-195-5p as an independent prognostic factor in the TCGA LUAD dataset. **P < 0.01; ***P < 0.001.